Are you searching for new avenues to treat your depression? With the introduction of Spravato® in our NY clinics, we at NY Ketamine Infusions are making strides to offer you innovative options for your mental health. Spravato® is an FDA-approved esketamine nasal spray specifically designed to treat Treatment-Resistant Depression and Major Depressive Disorder. As we prepare for the launch of this groundbreaking treatment, we’re excited to share how it can be a game-changer in your journey toward healing.
What Is Spravato®?
Spravato® is an FDA-approved esketamine nasal spray that offers a new approach to treating Treatment-Resistant Depression and Major Depressive Disorder. While it’s important to consider traditional therapies, Spravato® presents an option when those methods fall short. It’s also crucial to note that Spravato® is administered under strict safety guidelines in a certified environment, which makes it a reliable choice for patients needing close monitoring. Only certified providers can offer this treatment, ensuring you receive the highest standard of care.
Spravato® (esketamine) CIII is FDA-approved for two indications:
- Treatment-Resistant Depression (TRD) in adults, either as monotherapy or alongside an oral antidepressant
- Depressive symptoms in adults with Major Depressive Disorder (MDD) with acute suicidal ideation or behavior, used in combination with an oral antidepressant
Spravato® is only available through a certified treatment center as part of the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) program. At NY Ketamine Infusions, all Spravato® treatments are administered on-site under direct supervision by trained clinical staff. Patients are monitored for at least two hours following each dose. Home use is not permitted.
Why We’re Adding Spravato®
At NY Ketamine Infusions, we strive to provide you with cutting-edge therapies that truly make a difference. Dr. Mazharuddin shares his perspective, stating, “Spravato® gives us another clinically proven way to help people who haven’t responded to traditional treatments. For patients struggling with Treatment-Resistant Depression, more options can mean more hope.” This new treatment enhances our existing offerings, giving patients like you another pathway to explore in your battle against depression.
How Spravato® Fits Into Our Treatment Philosophy
You might wonder how Spravato® aligns with our mission at NY Ketamine Infusions. Dr. Mazharuddin emphasizes, “Our mission has always been to offer the safest, most effective treatments available. Adding Spravato® reflects our ongoing commitment to bringing cutting-edge therapies to the people who need them most.” We believe that everyone deserves access to effective treatments, and the addition of Spravato® is a testament to our dedication to your mental health journey.
It’s essential to understand that Spravato® will be offering a complementary option, not a replacement for our existing IV ketamine infusion therapy. Our well-established infusion treatment has shown remarkable success for many patients, and this new option allows even more flexibility in treatment plans.
What to Expect When It Launches
As we approach the launch of Spravato®, we want you to feel informed and confident about what to expect. When it becomes available, “Spravato® is administered under strict safety guidelines in a certified environment,” Dr. Mazharuddin assures. “Our team will be there with you every step of the way—from screening to post-treatment observation.” We understand that navigating new therapies can feel overwhelming, but rest assured that our experienced team will guide you throughout the entire process.
With over 12 years of experience and more than 8,000 patients treated, NY Ketamine Infusions is recognized as the most experienced ketamine clinic in the nation.
Final Thoughts
As we gear up to offer Spravato® at our NY clinics, our mission remains clear: providing you with the safest and most effective treatments for your mental health. With this new option on the horizon, we’re excited about the possibilities it brings. If you’re exploring new depression treatments in NYC, there’s never been a better time to reach out and discover what we can do for you.
Important Safety Information:
Spravato® may cause sedation, dissociation, and respiratory depression, and it carries the potential for abuse and misuse. Patients should be closely monitored for suicidal thoughts and behaviors. Blood pressure will be monitored during and after treatment, and this medication is not recommended during pregnancy.
At NY Ketamine Infusions, we have treated more than 8,000 patients since opening in 2012. Spravato® is offered as an additional treatment option—complementing our longstanding IV ketamine program. Both modalities are supported by evidence and may suit different patient needs. Your care team will work with you to determine which path best aligns with your medical history and treatment goals.
Get in Touch
Don’t wait for the launch—contact us today to learn more about our existing treatments and how Spravato® can serve as part of your personalized care plan. Visit our contact page here to get started.
This content is for informational purposes only and is not a substitute for professional medical advice. SPRAVATO® is only available through a certified treatment center under the FDA REMS program, with on-site monitoring and no home use permitted. Please see the Full Prescribing Information for additional safety details.